SCHEMBL6774475

SCHEMBL6774475

COC(=O)c1ccc(C(=O)O)cc1Oc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.66
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 1/20 0.50
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
ATM Q13315 1/20 0.50
AKR1C3 P42330 1/20 0.50
HSD17B10 Q99714 1/20 0.49
SLC6A3 Q01959 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA7 P43166 1/20 0.47
TPMT P51580 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL490297 0.92 KDM4E (0.58) TTRKDM4EALDH1A1GLAGAA
SCHEMBL649980 0.85 TTR (0.66) TTRKDM4EAKR1C3SRD5A2NR1H4
SCHEMBL490298 0.84 TTR (0.57) TTRKDM4EALDH1A1AKR1C3HSD17B10
Hydrochloric Acid SCHEMBL28567730 0.84 TTR (0.64) TTRKDM4EAKR1C3SRD5A2NR1H4
Hydrochloric Acid SCHEMBL10485517 0.84 TTR (0.64) TTRKDM4EAKR1C3SRD5A2NR1H4
SCHEMBL7019824 0.82 CA12 (0.65) TTRKDM4EALDH1A1GLAGAA
SCHEMBL30221732 0.82 CA12 (0.65) TTRKDM4EALDH1A1GLAGAA
SCHEMBL18224326 0.82 KDM4E (0.49) TTRKDM4EALDH1A1GLAGAA
SCHEMBL21723102 0.82 ABL1 (0.54) KDM4EALDH1A1GAAHPGDATM
SCHEMBL1741581 0.82 SLC6A3 (0.51) KDM4EALDH1A1HPGDHSD17B10SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
EP-0873123-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2003-04-09 EP disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed
EP-0873123-A4 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-02-03 EP disclosed
EP-0873123-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-10-28 EP disclosed
WO-1997017070-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 TTR 1325/4885KDM4E 3061/4885ALDH1A1 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.